Yu‐Li Lin
Impact in
- Biochemistry top 0.5%
- Phytochemicals and Antioxidant Activities
Papers in
- Epidemiology 16
- Hepatitis B Virus Studies 4
- Immunology 15
- Immunotherapy and Immune Responses 7
- Immune Cell Function and Interaction 6
- Co-authors
- Ju‐Li Lin (1 shared paper)Jen‐Kun Lin (2 shared papers)Yu‐Chih Liang (9 shared papers)Bor‐Luen Chiang (20 shared papers)Yong‐Fang Kuo (13 shared papers)Jen‐Kun Lin (3 shared papers)I-Ming Juan (3 shared papers)James S. Goodwin (7 shared papers)
- Journals
- Clinical & Experimental Immunology (3 papers)Annals of Pharmacotherapy (3 papers)Vaccine (3 papers)PLoS ONE (3 papers)International Journal of Hydrogen Energy (3 papers)
- Partner nations
- TaiwanUnited StatesItaly
In The Last Decade
Yu‐Li Lin
86 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 156
- Biochemistry 577
- Applied Microbiology and Biotechnology 118
- Pathology and Forensic Medicine 878
- Complementary and alternative medicine 280
- Pharmacology 469
Countries citing papers authored by Yu‐Li Lin
This map shows the geographic impact of Yu‐Li Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Li Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Li Lin more than expected).
Fields of papers citing papers by Yu‐Li Lin
This network shows the impact of papers produced by Yu‐Li Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Li Lin. The network helps show where Yu‐Li Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu‐Li Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. | 1997 | 492 |
| 2 | 1997 | 438 | |
| 3 | 1996 | 284 | |
| 4 | 2014 | 161 | |
| 5 | 2005 | 158 | |
| 6 | 2010 | 147 | |
| 7 | 1999 | 143 | |
| 8 | 1999 | 140 | |
| 9 | 2002 | 108 | |
| 10 | 2000 | 105 | |
| 11 | 2012 | 97 | |
| 12 | 1998 | 90 | |
| 13 | 2006 | 78 | |
| 14 | 2006 | 73 | |
| 15 | 2009 | 71 | |
| 16 | 2010 | 70 | |
| 17 | 2012 | 69 | |
| 18 | 2007 | 66 | |
| 19 | 2006 | 64 | |
| 20 | 2019 | 62 |
About Yu‐Li Lin
Yu‐Li Lin is a scholar working on Epidemiology, Immunology, Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Oncology, having authored 90 papers that have together received 4.1k indexed citations. Recurring topics across this work include Viral Infections and Immunology Research (9 papers), Tea Polyphenols and Effects (8 papers), Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (6 papers), Animal Disease Management and Epidemiology (5 papers), Hepatitis B Virus Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Viral gastroenteritis research and epidemiology (4 papers). The work is most often cited by research in Biochemistry (577 citations), Applied Microbiology and Biotechnology (118 citations), Pathology and Forensic Medicine (878 citations), Complementary and alternative medicine (280 citations) and Pharmacology (469 citations). Yu‐Li Lin has collaborated with scholars based in Taiwan, United States and Italy. Frequent co-authors include Ju‐Li Lin, Jen‐Kun Lin, Yu‐Chih Liang, Bor‐Luen Chiang, Yong‐Fang Kuo, Jen‐Kun Lin, I-Ming Juan, James S. Goodwin, Ying-Ling Chen and Mukaila A. Raji. Their work appears in journals such as Clinical & Experimental Immunology, Annals of Pharmacotherapy, Vaccine, PLoS ONE and International Journal of Hydrogen Energy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.